Showing results (271-280 of 453) with videos related to
Sort By:
Pageof 46
International Journal of Cancer|March 7, 2013
Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 yearsAnders Christensson, Caroline Savage, Daniel D Sjoberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened populationDavid Ulmert, Angel M Serio, Matthew F O'Brien, et al.Urology|January 29, 2014
Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimensRiina-Minna Väänänen, Hans Lilja, Leni Kauko, et al.Urology|August 27, 2021
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate VolumeEmily A Vertosick, Stephen Zappala, Sanoj Punnen, et al.BJU International|March 20, 2015
Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decadesNicola Fossati, Niccolò M Passoni, Marco Moschini, et al.Clinical Trials (London, England)|June 19, 2024
Optimizing accrual to a large-scale, clinically integrated randomized trial in anesthesiology: A 2-year analysis of recruitmentHanae K Tokita, Melissa Assel, Joanna Serafin, et al.Cancer|August 16, 2023
The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomyChristopher D Gaffney, Amy L Tin, Jonathan Fainberg, et al.BMC Medicine|February 19, 2008
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control studyDavid Ulmert, Angel M Cronin, Thomas Björk, et al.JNCI Cancer Spectrum|September 18, 2024
Clinical utility of an artificial intelligence radiomics-based tool for risk stratification of pulmonary nodulesRoger Y Kim, Clarisa Yee, Sana Zeb, et al.The Journal of Urology|August 28, 2023
Same-Day Discharge vs Inpatient Robotic-Assisted Radical Prostatectomy: Complications, Time-Driven Activity-Based Costing, and Patient SatisfactionEmily Cheng, Sofia Gereta, Tenny R Zhang, et al.Pageof 46